-
Actinium Pharmaceuticals Announces Reverse Stock Split
Post on 8/10/20
-
Citius Pharmaceuticals Closes $9.6M Bought Deal Offering
Post on 8/10/20
-
Healthify Partners with Algorex
Post on 8/10/20
-
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
Post on 8/10/20
-
Immunic Closes $103.5M Public Offering
Post on 8/10/20
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
Post on 8/10/20
-
Intercept Pharmaceuticals Reports Second Quarter 2020 Financial Results
Post on 8/10/20
-
Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
Post on 8/10/20
-
PTC Therapeutics Looks Like A Better Value After Recent Pullback
Post on 8/10/20
-
Pfizer to Co-Manufacture Coronavirus Drug Remdesivir
Post on 8/10/20
-
Is Pfizer Stock a Buy?
Post on 8/10/20
-
This Could Be the Ace in the Hole for Johnson & Johnson's COVID-19 Vaccine
Post on 8/10/20
-
Why the Market Hates the Teladoc-Livongo Deal
Post on 8/10/20
-
Is Teladoc a Top Stock to Buy Now?
Post on 8/10/20
-
Is It Too Late to Buy Teladoc Stock?
Post on 8/10/20
-
Why Teladoc Stock Soared 25% in July but Is Down 19% in August
Post on 8/10/20
-
Regeneron Prices Public Offering of Senior Unsecured Notes
Post on 8/9/20
-
Cellectis Provides Business Update
Post on 8/9/20
-
Pfizer Announces Agreement with Gilead
Post on 8/7/20
-
Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
Post on 8/7/20
-
Biohaven Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street
Post on 8/7/20
-
Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Post on 8/7/20
-
Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound
Post on 8/7/20
-
Celldex Provides Corporate Update
Post on 8/6/20
-
Interview with Guy D’Andrea, Founder and Managing Partner of Discern Health
Post on 8/6/20
New York
